1.
Blauvelt A, Pink A, Worm M, Langley R, Costanzo A, Gjerum L, Jorgensen E, Corriveau J, Guttman-Yassky E. COVID-19 in tralokinumab-treated patients with moderate-to- severe atopic dermatitis: case series from the ECZTEND long- term extension trial. J of Skin [Internet]. 2021 Nov. 5 [cited 2024 Jul. 3];5(6):s58. Available from: https://jofskin.org/33014/index.php/skin/article/view/1409